Australia: Boston Scientific Neuromodulation Owns Trademark for 'CELESTIA'

Australia, March 3 -- Boston Scientific Neuromodulation Corp., owns the trademark (2609260) for 'CELESTIA' till July 17, 2035.

Status: protected: Registered/protected

Classes: 9 [Electrical leads, clinician programming software and battery chargers for implantable spinal cord stimulation systems.] and 10 [Implantable spinal cord stimulation systems comprised of implantable pulse generators (IPGs), external trial stimulators, and external therapy controllers, for use in the treatment of pain.]

Type of Mark: Word

Date of Acceptance: Dec. 22, 2025

Registration Advertised: March 2

For further details contact Spruson & Ferguson and Lori A. Ruhly Quarles & Brady LLP .

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2609260.

Disclaimer: Curated by HT Syndication.